Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation
Unknown status
Astellas Pharma Korea, Inc.
Phase 4
2010-04-01
This study is to evaluate safety and prophylaxis effect of micafungin after hematopoietic
stem cell transplantation. Micafungin is administered until confirmation of neutrophil
engraftment or treatment failure.
Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation
Unknown status
Asan Medical Center
Phase 4
2010-04-01
This study is to evaluate safety and prophylaxis effect of micafungin after hematopoietic
stem cell transplantation. Micafungin is administered until confirmation of neutrophil
engraftment or treatment failure.
Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases
Completed
Yonsei University
Phase 2
2011-06-01
This study of chemotherapy occurred during the neutropenic fever in patients with antibiotic
refractory fever. The investigators evaluate efficacy and safety of micafungin sodium
(mycamine ® Injection) 100mg dose compare to itraconazole (Sporanox ® Injection) 200mg as a
control and this study is prospective, randomized, non-inferiority trials.
Therefore, this study was planned for review of the safety and efficacy in korean patients.
Micafungin Prevention Study for Invasive Fungal Disease in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
Unknown status
Seoul National University Hospital
Phase 2
2011-08-01
This study is to evaluate safety and prophylaxis effect of micafungin after hematopoietic
stem cell transplantation. Micafungin is administered until confirmation of neutrophil
engraftment or treatment failure.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
